Matilde Navarro

16.3k total citations · 4 hit papers
75 papers, 9.9k citations indexed

About

Matilde Navarro is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Matilde Navarro has authored 75 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 43 papers in Pathology and Forensic Medicine and 19 papers in Surgery. Recurrent topics in Matilde Navarro's work include Genetic factors in colorectal cancer (42 papers), Colorectal Cancer Treatments and Studies (27 papers) and Colorectal Cancer Screening and Detection (16 papers). Matilde Navarro is often cited by papers focused on Genetic factors in colorectal cancer (42 papers), Colorectal Cancer Treatments and Studies (27 papers) and Colorectal Cancer Screening and Detection (16 papers). Matilde Navarro collaborates with scholars based in Spain, France and United Kingdom. Matilde Navarro's co-authors include Josep Tabernero, C. Boni, Thierry André, Tamas Hickish, C. Topham, Aimery de Gramont, John Bridgewater, Philip R. Clingan, Lucile Awad and Marta Zaninelli and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Matilde Navarro

72 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

2004 2.7k citations Matilde Navarro et al. profile →
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

2000 2.5k citations David Cunningham, Matilde Navarro et al. The Lancet profile →
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

2009 1.6k citations Matilde Navarro et al. profile →
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer

1998 786 citations Philippe Rougier, Eric Van Cutsem et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matilde Navarro Spain	27	8.2k	2.2k	2.2k	2.1k	1.6k	75	9.9k
Eduardo Díaz‐Rubio Spain	49	8.7k 1.1×	2.4k 1.1×	3.5k 1.6×	1.9k 0.9×	2.0k 1.3×	351	12.0k
Andrea Bonetti Italy	30	6.2k 0.8×	2.1k 0.9×	1.9k 0.9×	1.2k 0.6×	1.1k 0.7×	153	8.1k
Christophe Tournigand France	42	7.0k 0.9×	2.4k 1.1×	3.0k 1.4×	1.2k 0.6×	949 0.6×	256	9.5k
Miriam Koopman Netherlands	41	5.7k 0.7×	1.8k 0.8×	1.9k 0.9×	2.0k 1.0×	1.1k 0.7×	222	8.0k
Jim Cassidy United Kingdom	42	9.4k 1.2×	2.3k 1.0×	3.1k 1.4×	1.5k 0.7×	1.5k 1.0×	122	11.7k
Jean A. Maroun Canada	35	7.4k 0.9×	2.1k 0.9×	2.6k 1.2×	1.7k 0.8×	1.4k 0.9×	136	9.6k
C. Boni Italy	34	11.0k 1.3×	3.3k 1.5×	5.5k 2.5×	2.1k 1.0×	1.7k 1.0×	122	13.9k
Harry Bleiberg Belgium	40	7.2k 0.9×	2.5k 1.1×	4.2k 1.9×	1.4k 0.7×	1.7k 1.0×	163	10.2k
H. Cortés-Funes Spain	44	6.4k 0.8×	2.1k 0.9×	2.6k 1.2×	872 0.4×	1.8k 1.1×	192	9.6k
Alberto Zaniboni Italy	40	6.3k 0.8×	1.5k 0.7×	2.5k 1.1×	1.9k 0.9×	1.1k 0.7×	301	8.1k

Countries citing papers authored by Matilde Navarro

Since Specialization

Citations

This map shows the geographic impact of Matilde Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilde Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilde Navarro more than expected).

Fields of papers citing papers by Matilde Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilde Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilde Navarro. The network helps show where Matilde Navarro may publish in the future.

Co-authorship network of co-authors of Matilde Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Matilde Navarro. A scholar is included among the top collaborators of Matilde Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilde Navarro. Matilde Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mur, Pilar, Mariona Terradas, Sandra García‐Mulero, et al.. (2022). Potential Involvement of NSD1, KRT24 and ACACA in the Genetic Predisposition to Colorectal Cancer. Cancers. 14(3). 699–699. 2 indexed citations

Navarro, Matilde, Àlex Teulé, Ares Solanes, et al.. (2021). Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. Cancers 2020, 12, 3419. Cancers. 13(13). 3104–3104. 1 indexed citations

Mur, Pilar, Núria Bonifaci, Anna Díez-Villanueva, et al.. (2021). Non-Lynch Familial and Early-Onset Colorectal Cancer Explained by Accumulation of Low-Risk Genetic Variants. Cancers. 13(15). 3857–3857. 5 indexed citations

Navarro, Matilde, Àlex Teulé, Ares Solanes, et al.. (2020). Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. Cancers. 12(11). 3419–3419. 12 indexed citations

Belhadj, Sami, Mariona Terradas, Gemma Aiza, et al.. (2020). Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review. Human Mutation. 41(9). 1563–1576. 30 indexed citations

Mur, Pilar, Ann‐Sofie Jemth, Nuno Amaral, et al.. (2018). Germline variation in the oxidative DNA repair genesNUDT1andOGG1is not associated with hereditary colorectal cancer or polyposis. Human Mutation. 39(9). 1214–1225. 5 indexed citations

Feliubadaló, Lídia, Raúl Tonda, Jean-Rémi Trotta, et al.. (2017). Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer. Scientific Reports. 7(1). 37984–37984. 31 indexed citations

Bellido, Fernando, Marta Pineda, Gemma Aiza, et al.. (2015). POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genetics in Medicine. 18(4). 325–332. 175 indexed citations

Bellido, Fernando, Marta Pineda, Rebeca Sanz‐Pamplona, et al.. (2014). Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency. European Journal of Cancer. 50(11). 1964–1972. 5 indexed citations

10.

Mur, Pilar, Marta Pineda, Atocha Romero, et al.. (2013). Identification of a founder EPCAM deletion in Spanish Lynch syndrome families. Clinical Genetics. 85(3). 260–266. 9 indexed citations

11.

Borràs, Ester, Marta Pineda, Angela Brieger, et al.. (2012). Comprehensive functional assessment ofMLH1variants of unknown significance. Human Mutation. 33(11). 1576–1588. 24 indexed citations

12.

Ychou, Marc, Werner Hohenberger, Simon Thézenas, et al.. (2009). A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Annals of Oncology. 20(12). 1964–1970. 189 indexed citations

13.

Rothenberg, Mace L., John V. Cox, Charles Butts, et al.. (2008). Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. Annals of Oncology. 19(10). 1720–1726. 156 indexed citations

14.

Ribes, Josepa, Matilde Navarro, Ramón Clèries, et al.. (2008). Colorectal cancer mortality in Spain: trends and projections for 1985–2019. European Journal of Gastroenterology & Hepatology. 21(1). 92–100. 28 indexed citations

15.

Izquierdo, Miguel, Margarita García, Vicente Valentí, et al.. (2006). A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours. European Journal of Cancer. 42(12). 1789–1796. 12 indexed citations

16.

Navarro, Matilde, E. Dotor, Fernando Rivera, et al.. (2006). A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 66(1). 201–205. 54 indexed citations

17.

Parés, David, Sebastiano Biondo, Ignacio Blanco, et al.. (2006). Estado actual del seguimiento del área gastroduodenal en la poliposis adenomatosa familiar. Gastroenterología y Hepatología. 29(1). 15–21. 2 indexed citations

18.

Abad, Albert, Alfredo Carrato, Matilde Navarro, et al.. (2005). Two Consecutive Phase II Trials of Biweekly Oxaliplatin plus Weekly 48-Hour Continuous Infusion of Nonmodulated High-Dose 5-Fluorouracil as First-Line Treatment for Advanced Colorectal Cancer. Clinical Colorectal Cancer. 4(6). 384–389. 7 indexed citations

19.

Rougier, Philippe, Eric Van Cutsem, Emilio Bajetta, et al.. (1998). Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. The Lancet. 352(9138). 1407–1412. 786 indexed citations breakdown →

20.

Meunier, L., et al.. (1995). [Multiple cutaneous carcinoma and chronic lymphoid leukemia].. PubMed. 122(1-2). 23–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact